CSIMarket Company Name, Ticker, Competitors, else..
 
Bridgebio Pharma Inc   (NASDAQ: BBIO)
 

Bridgebio Pharma Inc's Suppliers Performance

BBIO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
BBIO Costs vs Sales of Suppliers Growth Bridgebio Pharma Inc recorded an increase in cost of sales by 311.88 % year on year, sequentially cost of sales grew by 51.38 % in Q2.

• More on BBIO Suppliers



Bridgebio Pharma Inc recorded increase in cost of sales by 311.88 % year on year, sequentially cost of sales grew by 51.38 % in Q2.

• More on BBIO Suppliers




Bridgebio Pharma Inc's Comment on Supply Chain


The company sources raw materials, drug substances, drug products, and packaging for commercial products, preclinical research, and ongoing clinical trials. It has established long-term manufacturing agreements with Contract Manufacturing Organizations (CMOs) to produce and support commercial sales of Attruby in the U.S. and Beyonttra in select markets outside the U.S. The company intends to continue utilizing CMOs for later-stage development and commercialization of its product candidates. Employees and third-party consultants with manufacturing expertise manage relationships with contract manufacturers.

Bridgebio Pharma Inc's Comment on Supply Chain


The company sources raw materials, drug substances, drug products, and packaging for commercial products, preclinical research, and ongoing clinical trials. It has established long-term manufacturing agreements with Contract Manufacturing Organizations (CMOs) to produce and support commercial sales of Attruby in the U.S. and Beyonttra in select markets outside the U.S. The company intends to continue utilizing CMOs for later-stage development and commercialization of its product candidates. Employees and third-party consultants with manufacturing expertise manage relationships with contract manufacturers.







BBIO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bridgebio Pharma Inc 12,837.68 713.07 -702.02 839
SUBTOTAL 0.00 0.00 0.00 -


Sources: Bridgebio Pharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bridgebio Pharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.